DK3334838T3 - Fremgangsmåde til kvantificeringen af faecalibacterium prausnitzii phylogruppe i- og/eller phylogruppe ii-medlemmer og anvendelsen deraf som biomarkører - Google Patents
Fremgangsmåde til kvantificeringen af faecalibacterium prausnitzii phylogruppe i- og/eller phylogruppe ii-medlemmer og anvendelsen deraf som biomarkører Download PDFInfo
- Publication number
- DK3334838T3 DK3334838T3 DK16754468.3T DK16754468T DK3334838T3 DK 3334838 T3 DK3334838 T3 DK 3334838T3 DK 16754468 T DK16754468 T DK 16754468T DK 3334838 T3 DK3334838 T3 DK 3334838T3
- Authority
- DK
- Denmark
- Prior art keywords
- phylogrupe
- phylograph
- biomarkers
- quantification
- members
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15382427.1A EP3130680A1 (en) | 2015-08-11 | 2015-08-11 | Method for the detection, follow up and/or classification of intestinal diseases |
| PCT/EP2016/069188 WO2017025617A1 (en) | 2015-08-11 | 2016-08-11 | Method for the quantification of faecalibacterium prausnitzii phylogroup i and/or phylogroup ii members and the use thereof as biomarkers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3334838T3 true DK3334838T3 (da) | 2021-11-15 |
Family
ID=53938288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16754468.3T DK3334838T3 (da) | 2015-08-11 | 2016-08-11 | Fremgangsmåde til kvantificeringen af faecalibacterium prausnitzii phylogruppe i- og/eller phylogruppe ii-medlemmer og anvendelsen deraf som biomarkører |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US11299788B2 (da) |
| EP (2) | EP3130680A1 (da) |
| JP (2) | JP7095210B2 (da) |
| KR (1) | KR20180048696A (da) |
| CN (2) | CN115976239A (da) |
| AU (1) | AU2016306627B2 (da) |
| CA (1) | CA2995308A1 (da) |
| DK (1) | DK3334838T3 (da) |
| ES (1) | ES2901465T3 (da) |
| HK (1) | HK1257108A1 (da) |
| HR (1) | HRP20211757T1 (da) |
| IL (1) | IL257461B (da) |
| MX (1) | MX2018001697A (da) |
| PT (1) | PT3334838T (da) |
| SI (1) | SI3334838T1 (da) |
| WO (1) | WO2017025617A1 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10138508B2 (en) * | 2014-01-20 | 2018-11-27 | Fujirebio Inc. | Method for measuring modified nucleobase using guide probe, and kit therefor |
| JP6898674B2 (ja) | 2017-06-02 | 2021-07-07 | グッドガット エッセ．エッレ． | ディスバイオシスの治療のために用いられるブドウ果皮 |
| CA3084012A1 (en) * | 2017-11-02 | 2019-05-09 | Mitsubishi Chemical Corporation | Intraoral examination method using information on bacterial group related to clinical indexes |
| US11649508B2 (en) | 2017-12-15 | 2023-05-16 | Vib Vzw | Inflammation associated, low cell count enterotype |
| CZ2018456A3 (cs) * | 2018-09-08 | 2020-01-02 | Výzkumný ústav veterinárního lékařství, v. v. i. | Způsob detekce Faecalibacterium prausnitzii pomocí metody PCR v reálném čase a sada primerů pro tento způsob detekce F. prausnitzii |
| CN112930407A (zh) * | 2018-11-02 | 2021-06-08 | 加利福尼亚大学董事会 | 使用非人类核酸诊断和治疗癌症的方法 |
| CN114207150A (zh) | 2019-03-13 | 2022-03-18 | 古德盖特公司 | 筛查、诊断和/或监测结直肠晚期肿瘤、晚期腺瘤和/或结直肠癌的改进方法 |
| WO2023049838A1 (en) * | 2021-09-23 | 2023-03-30 | Flagship Pioneering Innovations Vi, Llc | Diagnosis and treatment of diseases and conditions of the intestinal tract |
| CN114015761A (zh) * | 2021-09-24 | 2022-02-08 | 上海交通大学医学院附属瑞金医院 | 粪便tyrDC基因丰度作为预测左旋多巴疗效生物标志物的应用 |
| EP4386091A1 (en) * | 2022-12-14 | 2024-06-19 | The BioArte Limited | A method for taxonomic classification up to species level of bacteria |
| WO2024181851A1 (en) * | 2023-02-28 | 2024-09-06 | Enterobiome Inc. | Method for predicting therapeutic response of pharmabiotics and treatment method of various diseases using the same |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6174681B1 (en) | 1999-03-05 | 2001-01-16 | Mayo Foundation For Medical Education And Research | Method and probe set for detecting cancer |
| FR2820145B1 (fr) * | 2001-01-31 | 2004-01-23 | Aventis Pharma Sa | Souche de levure produisant des steroides de facon autonome |
| AU2003245465A1 (en) | 2002-02-13 | 2003-09-04 | Medimolecular Pty. Ltd. | Method of isolating nucleic acids from stool samples |
| US7696334B1 (en) * | 2002-12-05 | 2010-04-13 | Rosetta Genomics, Ltd. | Bioinformatically detectable human herpesvirus 5 regulatory gene |
| EP1752536A4 (en) * | 2004-05-11 | 2008-04-16 | Alphagen Co Ltd | POLYNUCLEOTIDE CAUSING RNA INTERFERENCE AND METHOD OF REGULATING GENE EXPRESSION WITH THE USE OF THE SAME |
| US7323308B2 (en) | 2004-09-03 | 2008-01-29 | Affymetrix, Inc. | Methods of genetic analysis of E. coli |
| US7901882B2 (en) * | 2006-03-31 | 2011-03-08 | Affymetrix, Inc. | Analysis of methylation using nucleic acid arrays |
| EP2057465A4 (en) * | 2006-08-09 | 2010-04-21 | Homestead Clinical Corp | SPECIFIC ORGAN PROTEINS AND METHODS OF USE |
| WO2011009099A1 (en) * | 2009-07-16 | 2011-01-20 | The Regents Of The University Of California | Metabolic biomarkers of crohn's disease |
| US20120238468A1 (en) * | 2009-10-05 | 2012-09-20 | Aak Patent B.V. | Methods for diagnosing irritable bowel syndrome |
| US8906610B2 (en) * | 2010-02-08 | 2014-12-09 | The Regents Of The University Of California | Using phylogenetic probes for quantification of stable isotope labeling and microbial community analysis |
| US20140171339A1 (en) | 2011-06-06 | 2014-06-19 | The University Of North Carolina At Chapel Hill | Methods and kits for detecting adenomas, colorectal cancer, and uses thereof |
| EP4170031A1 (en) * | 2012-10-23 | 2023-04-26 | Caris Science, Inc. | Aptamers and uses thereof |
| CN105228635A (zh) | 2013-03-05 | 2016-01-06 | 格罗宁根大学 | Faecalibacterium prausnitzii HTF-F（DSM 26943）在抑制炎症中的应用 |
| WO2014138999A1 (en) | 2013-03-14 | 2014-09-18 | University Of Ottawa | Methods for the diagnosis and treatment of inflammatory bowel disease |
| WO2014197607A1 (en) | 2013-06-05 | 2014-12-11 | The Regents Of The University Of California | Detection of tick-borne diseases |
| EP2876167A1 (en) * | 2013-11-21 | 2015-05-27 | Institut Gustave Roussy | Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-,pro- or synbiotics) for improving the efficacy of a cancer treatment |
| ES2661684T3 (es) * | 2014-03-03 | 2018-04-03 | Fundacio Institut D'investigació Biomèdica De Girona Dr. Josep Trueta | Método para diagnosticar cáncer colorrectal a partir de una muestra de heces humanas mediante PCR cuantitativa |
| CN104745620A (zh) * | 2015-03-03 | 2015-07-01 | 昆明理工大学 | 蚕豆vfpp1c基因的植物表达载体及其应用 |
-
2015
- 2015-08-11 EP EP15382427.1A patent/EP3130680A1/en not_active Withdrawn
-
2016
- 2016-08-11 SI SI201631380T patent/SI3334838T1/sl unknown
- 2016-08-11 CN CN202211643379.9A patent/CN115976239A/zh active Pending
- 2016-08-11 PT PT167544683T patent/PT3334838T/pt unknown
- 2016-08-11 CN CN201680059564.XA patent/CN108474037A/zh active Pending
- 2016-08-11 EP EP16754468.3A patent/EP3334838B1/en active Active
- 2016-08-11 DK DK16754468.3T patent/DK3334838T3/da active
- 2016-08-11 WO PCT/EP2016/069188 patent/WO2017025617A1/en active Application Filing
- 2016-08-11 HR HRP20211757TT patent/HRP20211757T1/hr unknown
- 2016-08-11 ES ES16754468T patent/ES2901465T3/es active Active
- 2016-08-11 AU AU2016306627A patent/AU2016306627B2/en active Active
- 2016-08-11 JP JP2018527012A patent/JP7095210B2/ja active Active
- 2016-08-11 CA CA2995308A patent/CA2995308A1/en active Pending
- 2016-08-11 KR KR1020187006886A patent/KR20180048696A/ko active IP Right Grant
- 2016-08-11 US US15/751,805 patent/US11299788B2/en active Active
- 2016-08-11 MX MX2018001697A patent/MX2018001697A/es unknown
-
2018
- 2018-02-11 IL IL257461A patent/IL257461B/en unknown
- 2018-12-20 HK HK18116361.7A patent/HK1257108A1/zh unknown
-
2021
- 2021-10-22 JP JP2021173197A patent/JP2022031644A/ja active Pending
-
2022
- 2022-03-01 US US17/683,926 patent/US20220307075A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20220307075A1 (en) | 2022-09-29 |
| ES2901465T3 (es) | 2022-03-22 |
| PT3334838T (pt) | 2021-11-23 |
| EP3334838B1 (en) | 2021-10-06 |
| KR20180048696A (ko) | 2018-05-10 |
| AU2016306627A1 (en) | 2018-03-15 |
| SI3334838T1 (sl) | 2022-01-31 |
| IL257461B (en) | 2022-05-01 |
| IL257461A (en) | 2018-04-30 |
| HK1257108A1 (zh) | 2019-10-11 |
| EP3334838A1 (en) | 2018-06-20 |
| EP3130680A1 (en) | 2017-02-15 |
| CN108474037A (zh) | 2018-08-31 |
| WO2017025617A8 (en) | 2017-07-27 |
| CA2995308A1 (en) | 2017-02-16 |
| MX2018001697A (es) | 2019-04-29 |
| JP2018525035A (ja) | 2018-09-06 |
| US20190024146A1 (en) | 2019-01-24 |
| HRP20211757T1 (hr) | 2022-02-18 |
| CN115976239A (zh) | 2023-04-18 |
| JP7095210B2 (ja) | 2022-07-05 |
| JP2022031644A (ja) | 2022-02-22 |
| WO2017025617A1 (en) | 2017-02-16 |
| AU2016306627B2 (en) | 2022-01-13 |
| US11299788B2 (en) | 2022-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3334838T3 (da) | Fremgangsmåde til kvantificeringen af faecalibacterium prausnitzii phylogruppe i- og/eller phylogruppe ii-medlemmer og anvendelsen deraf som biomarkører | |
| DK3247371T3 (da) | Fremgangsmåder til oprensning af cannabinoider, sammensætninger og kits dertil | |
| DK3212208T3 (da) | Anvendelse af l. reuteri til forebyggelse eller behandling af mikrobiotadysbiose tidligt i livet | |
| DK3271358T3 (da) | Spirocykliske forbindelser som agonister af muscarin m1-receptor og/eller m4-receptor | |
| DK3277681T3 (da) | Imidazolonylquinoliner og deres anvendelse som atm-kinaseinhibitorer | |
| DK3370828T3 (da) | Oximforbindelse som agonister af muscarin m1- og/eller m4- receptoren | |
| DK3159406T3 (da) | Kit eller indretning til påvisning af øsufagus-cancer og fremgangsmåde til påvisning | |
| DK3213056T3 (da) | Fremgangsmåder til hurtig forberedelse af mærkede glycosylaminer og til analyse af glykosylerede biomolekyler, som giver samme baggrund | |
| DK3712279T3 (da) | Fremgangsmåder til diagnosticering og evaluering af non-alkoholisk steatohepatitis | |
| DK3341355T3 (da) | (s)-3-amino-4-(difluormethylenyl)cyclopent-1-en-1-carboxylsyre og tilhørende forbindelser som gaba-aminotransferaseinaktivatorer til behandling af epilepsi, afhængighed og hepatocellulært karcinom | |
| DK3283643T3 (da) | Midler til diagnosticering, forudsigelse eller monitorering af Pneumocystis pneumoni | |
| DK3466934T3 (da) | Sulfonamidforbindelser eller salt deraf som ribonukleotidreductase-inhibitorer til behandling af kræft | |
| DK3384274T3 (da) | Fremgangsmåder til prøvekarakterisering | |
| DK3393655T3 (da) | Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme | |
| DK3368683T3 (da) | Fremgangsmåde til kvantifikationen af pd-l1 | |
| DK3313833T3 (da) | Forbindelser og anvendelse deraf som inhibitorer af n-myristoyl-transferase | |
| BR112016019822A2 (pt) | Determinação enzimática de hba1c | |
| DK3320099T5 (da) | Membranforankret eller udskilt antistof til ekspression af lentivirale vektorer | |
| DK3497085T3 (da) | Sulfonamider som gpr40- og gpr120-agonister | |
| DK3422936T3 (da) | Apparat til prøveudtagning af en eller flere analytter | |
| DK3380526T3 (da) | Miljøvenlig fremgangsmåde til fremstilling af nanocellulose og derivater deraf | |
| DK3170784T3 (da) | Fremgangsmåde til drift af et ankerspil og ankerspil | |
| DK3172177T3 (da) | Mørtelsammensætning til en indendørs belægning eller beklædning | |
| DK3483617T3 (da) | Fremgangsmåde til latensmåling | |
| DK3700907T3 (da) | Hidtil ukendte pyrazolo-pyrrolo-pyrimidindion-derivater som p2x3-inhibitorer |